Watch Ticker

Aligos Therapeutics, Inc. Common Stock

Go to Aligos Therapeutics, Inc. Common Stock Website

$7.91

-0.09 (-1.12%)

Live

Previous Close

$8

Day Range

$7.45 - $8.2215

Previous Day Range

$7.42 - $8

Market Cap

$45.6 million USD

Day Vol.

47794

Previous Day Vol.

28840

Currency

USD

Primary Exchange

Nasdaq

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for no...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics, a clinical-stage biopharmaceutical company, announced that it granted a non-qualified stock option to a newly hired employee as an inducement to join the company.

Related tickers: ALGS.

Read Full Article

Aligos Therapeutics, Inc. - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics, a clinical-stage biopharmaceutical company, announced that it granted a non-qualified stock option to a newly hired employee as an inducement to join the company.

Related tickers: ALGS.

Read Full Article

Trending Tickers

Please sign in to view